Beth C. Seidenberg - Insider Trading & Ownership

Entity
Individual
Summary
The estimated net worth of Beth C. Seidenberg is at least $23.8M dollars as of October 30, 2024. Beth C. Seidenberg is the Director of Progyny, Inc. and owns shares of Progyny, Inc. (PGNY) stock worth about $8.67M. Beth C. Seidenberg is the Director of Sagimet Biosciences Inc. and owns shares of Sagimet Biosciences Inc. (SGMT) stock worth about $8.33M. Beth C. Seidenberg is the Director of Vera Therapeutics, Inc. and owns shares of Vera Therapeutics, Inc. (VERA) stock worth about $6.72M. Beth C. Seidenberg is the Director of Atara Biotherapeutics, Inc. and owns shares of Atara Biotherapeutics, Inc. (ATRA) stock worth about $45.1K.
All Insider Reports
All Insider Reports

Ownership of Beth C. Seidenberg

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PGNY Progyny, Inc. Director $8.67M May 23, 2024
SGMT Sagimet Biosciences Inc. Director $8.33M Jun 5, 2024
VERA Vera Therapeutics, Inc. Director $6.72M -$1.42M -17.4% Oct 28, 2024
ATRA Atara Biotherapeutics, Inc. Director $45.1K May 31, 2023
SLRN ACELYRIN, Inc. Director Jun 7, 2024
KYTX Kyverna Therapeutics, Inc. Director, 10%+ Owner Feb 12, 2024

Insider Transactions Reported by Beth C. Seidenberg:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.